Zhejiang Jianfeng Group Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Jianfeng Group Company Limited with three other
companies in this sector in China:
Shenzhen Hepalink Pharmaceutical Company Limited
sales of 2.26 billion Chinese Renmimbi [US$328.16 million]
of which 100%
was Pharmaceutical Manufacturing),
Shandong Lukang Pharmaceutical
(2.51 billion Chinese Renmimbi [US$363.86 million]
of which 67%
was Human Antibiotic), and
PKU HealthCare Corp Ltd
(2.07 billion Chinese Renmimbi [US$300.63 million]
of which 86%
was Merchandise&Material Selling).
Zhejiang Jianfeng Group Company Limited reported sales of 2.38 billion Chinese Renmimbi (US$345.49 million)
December of 2016.
increase of 5.4%
versus 2015, when the company's sales were 2.26 billion Chinese Renmimbi.
Sales at Zhejiang Jianfeng Group Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 45%).
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
27.2% in 2016, from
15.15 million Chinese Renmimbi to 19.26 million Chinese Renmimbi.
Zhejiang Jianfeng Group Company Limited also saw significant increases in sales in
Cement/construction Materials (up 7.3% to 956.15 million Chinese Renmimbi)
Health Products Industry (up 11.1% to 155.79 million Chinese Renmimbi)
Not all segments of Zhejiang Jianfeng Group Company Limited experienced an increase in sales in 2016:
sales of Other fell 13.2% to 178.64 million Chinese Renmimbi.